USPH

Business Context and Reporting Period

Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2006
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing pre- and post-operative care, sports injury treatment, and rehabilitation. As of December 31, 2006, the Company operated 292 clinics in 41 states. The business model primarily utilizes "Clinic Partnerships" (198 clinics) where the Company holds a majority limited partnership interest, and "Wholly-Owned Facilities" (94 clinics). The Company also manages four third-party facilities.

Key Financial Metrics

Operational Metrics: Total patient visits increased 7% to 1.38 million. Net patient revenue per visit was $96.72. The Company closed 31 unprofitable clinics and sold one during the year, reporting these as "Discontinued Operations."

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 7% to $135.2 million, driven by a 7% increase in patient visits and a slight increase in revenue per visit.
• Profitability Decline: Net income from continuing operations decreased 11% to $8.2 million. Total net income decreased 28% to $6.3 million.
• Discontinued Operations Impact: The decline in total net income was significantly impacted by a $1.9 million charge (net of tax) related to the closure of 31 clinics and the sale of one clinic. This included $1.1 million in operating losses and $1.9 million in closure costs/impairment charges.
• Accounting Changes: The Company adopted SFAS No. 123R (Share-Based Payments) effective January 1, 2006, resulting in $0.6 million of equity compensation expense that reduced net income. Prior periods were not restated.
• Cost Increases: Clinic operating costs rose to 74% of net revenues (from 71% in 2005). Salaries and related costs increased 11%, and the provision for doubtful accounts increased 57% to $2.1 million.

Guidance, Outlook, and Risks

Outlook and Strategy: Management intends to continue developing new clinics and opening satellite locations. The Company plans to evaluate acquisition opportunities. Management believes existing cash and cash equivalents ($11.5 million including marketable securities) are sufficient to fund operations and development through at least December 2007. Large acquisitions would likely be financed with debt.

Key Risks and Contingencies:

• Reimbursement Environment: Approximately 81% of revenue comes from third-party payors (managed care, commercial insurance, workers' comp). The Company is subject to the Medicare Cap ($1,740 for 2006, $1,780 for 2007), which may result in lost revenue if exceptions are not granted.
• Regulatory Compliance: The business is subject to extensive federal and state regulations, including the Fraud and Abuse Law, Stark Law, and HIPAA. Non-compliance could result in penalties or exclusion from government programs.
• Clinic Performance: The Company continues to close underperforming clinics. New clinics typically incur operating losses in their first year.
• Contingent Consideration: Recent acquisitions (Arizona, New Jersey, Alaska) include potential contingent payments totaling up to $2.475 million based on future operating results.

Investor Verification Checklist

• Discontinued Operations: Verify the specific financial impact of the 31 closed clinics and the one sold clinic, as these were reclassified and significantly impacted 2006 net income.
• Medicare Cap Exposure: Assess the Company's ability to obtain automatic or manual exceptions to the Medicare Cap, as failure to do so directly reduces revenue.
• Bad Debt Reserves: Review the 57% increase in the provision for doubtful accounts and the aging of receivables (27.7% over 120 days) to evaluate collection risks.
• Stock-Based Compensation: Note the impact of the new SFAS 123R standard on future earnings, as $1.0 million was expensed in 2006 with $2.4 million of future pre-tax expense remaining.
• Acquisition Integration: Monitor the performance of the 8-clinic Arizona acquisition and the associated contingent consideration obligations.